chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 0.94
Sex: U
Vaccine: HIBV
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and genders. The reporter stated that, on an unspecified date, an unknown number of doses of LIQUID PEDVAXHIB, (dose, lot#, expiration dates not provided) that were stored at 48 degrees F for 20 minutes, then exposed to 47 degrees for 9 minutes have been administered. No adverse effects were reported.   Follow up information had been received on 22-JUL-2014 from a receptionist. The reporter stated that there were two different lot numbers of LIQUID PEDVAXHIB that were included in the temperature excursion: Lot # J016188, expiration date: 02-OCT-2016 and lot # J015437, expiration date: 09-OCT-2016. The receptionist did not have any additional information to share.  Follow-up information has been received from the registered nurse who provided patients details. This report refers to a 11 months old patient of unknown gender. On 10-JUN-2014 the patient was vaccinated with a dose of LIQUID PEDVAXHIB (dose and route were not reported), lot#J016188, expiration date: 02-OCT-2016 that was improperly stored. No adverse effects were reported.  This is one of several reports received from the same reporter. Additional information is not expected.
Sex: M
Vaccine: VARZOS
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: This spontaneous report as received from a pharmacist refers to a male patient of unknown age. On 23-JUL-2014 the patient was inadvertently vaccinated subcutaneously with a second dose of ZOSTAVAX (dose 0.65 ml, lot# and expiration date were not reported). The patient had received the first dose of ZOSTAVAX about 8 years ago (approximately in 2006, dose, route, lot# and expiration date were not reported). The patient had forgotten that he had received ZOSTAVAX in the past so he requested it at the pharmacy on 23-JUL-2014 and was vaccinated.When he got home his wife reminded him that he already received ZOSTAVAX about 8 years ago (approximately in 2006). No symptoms were reported. No PQC (product quality complaint) was involved. Additional information has been requested.
Age: 0.13
Sex: U
Vaccine: HIBV
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and genders. The reporter stated that, on an unspecified date, an unknown number of doses of LIQUID PEDVAXHIB, (dose, lot#, expiration dates not provided) that were stored at 48 degrees F for 20 minutes, then exposed to 47 degrees for 9 minutes have been administered. No adverse effects were reported.   Follow up information had been received on 22-JUL-2014 from a receptionist. The reporter stated that there were two different lot numbers of LIQUID PEDVAXHIB that were included in the temperature excursion: Lot # J016188, expiration date: 02-OCT-2016 and lot # J015437, expiration date: 09-OCT-2016. The receptionist did not have any additional information to share.  Follow-up information has been received from the registered nurse who provided patients details. This report refers to a 6 weeks old patient of unknown gender. On 16-JUN-2014 the patient was vaccinated with a dose of LIQUID PEDVAXHIB (dose and route were not reported), lot#J016188, expiration date: 02-OCT-2016 that was improperly stored. No adverse effects were reported.  This is one of several reports received from the same reporter. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant concerning unspecified number of patients (details unspecified) of unknown age. On an unknown date the patients were vaccinated with improperly stored (Oka/Merck) VARIVAX (details unspecified). No adverse effects were reported. No concomitant therapy was reported. No product quality complaint was filed. The action taken was assessed as not applicable. The outcome of event was not reported. The causality was assessed as not related to the suspect therapy. Additional information has been requested.
Age: 3.0
Sex: M
Vaccine: DTAP, MMR
Symptoms: Circumstance or information capable of leading to medication error, Erythema, Injection site erythema, Injection site induration, Injection site nodule
Clinical narrative: ACCORDING TO PARENT'S STATEMENT: WAS A PAINFUL RED LUMP. AFTER 2 DAYS THE LUMP GREW IN SIZE. BIGGER THAN A SILVER DOLLAR. STILL PAINFUL AND HAS FEVER WAITING. ACCORDING TO DOCTOR'S VISIT REPORT STATING:3 yo male was here in Peds clinic 2 days ago and received DTaP#4 and Varicella #1 vaccines, DTaP was given in L thigh. Mom reports that when that vaccine was given, child reached down and grabbed the syringe and does not know if it pulled out or moved while the vaccine was still being given. Child developed a small knot in his left thigh that night, the following day child with redness, firmness and warmth at injection site. TTP but not affecting pt's activity, normal gait. No fevers. No problems with righ thigh (varicella) injection site. Child had no previous problems with prior DTaP vaccines.
Age: 3.0
Sex: M
Vaccine: DTAP, MMR
Symptoms: Injection site warmth, Mass, Pain, Pyrexia
Clinical narrative: ACCORDING TO PARENT'S STATEMENT: WAS A PAINFUL RED LUMP. AFTER 2 DAYS THE LUMP GREW IN SIZE. BIGGER THAN A SILVER DOLLAR. STILL PAINFUL AND HAS FEVER WAITING. ACCORDING TO DOCTOR'S VISIT REPORT STATING:3 yo male was here in Peds clinic 2 days ago and received DTaP#4 and Varicella #1 vaccines, DTaP was given in L thigh. Mom reports that when that vaccine was given, child reached down and grabbed the syringe and does not know if it pulled out or moved while the vaccine was still being given. Child developed a small knot in his left thigh that night, the following day child with redness, firmness and warmth at injection site. TTP but not affecting pt's activity, normal gait. No fevers. No problems with righ thigh (varicella) injection site. Child had no previous problems with prior DTaP vaccines.
Age: 46.0
Sex: F
Vaccine: PPV, VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Very red, swollen and painful injection site and around injection site.
Age: 1.27
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: This spontaneous report was received from a Physician refers to a 15 month old female patient. The patient had no pertinent medical history and known allergies. On 23-JUL-2014 the patient was vaccinated with her first dose of (Oka/Merck) VARIVAX lot#J012378, expiry date: 03-OCT-2015, 0.5ml, subcutaneously in the right thigh. No concomitant therapy was reported. On 29-JUL-2014, 7 days after onset of therapy the patient experienced chicken pox rash. No treatment was given. The patient's caretaker sought medical attention by office visit on 30-JUL-2014. However, no intervention initiated to prevent serious criteria as there was none. No product quality complaint was filed. The action taken was assessed as not applicable. No lab tests were performed. The outcome of chicken pox rash was reported as not recovered/not resolved. The causality was unspecified in the report. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster, Skin irritation
Clinical narrative: This spontaneous report was received from a physician via a company representative refers to a currently 8 year old female patient. No drug reactions/allergies were provided. The patient's medical history included previous staph infections. On 24-APR-2007, the patient was vaccinated with the first dose of (Oka/Merck) VARIVAX INJ (dose, route and lot number not provided), and on 18-MAY-2010, the patient was vaccinated with the second dose of (Oka/Merck) VARIVAX INJ (dose, route and lot number not provided). No co-suspect or concomitant therapies were reported. The physician stated that the patient complained of irritation on her back (date not specified). On 28-JUL-2014, the patient was seen at the doctor office and had a cluster of scabbing on her back; she had shingles. The physician reported that the patient never had chicken pox or shingles before. The treatment was acyclovir. No lab diagnostic studies were performed. At the time of the report, the outcome of the event was reported as not recovered/not resolved. Additional information has been requested.
Sex: U
Vaccine: HPV4, HPV4
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: This spontaneous report as received from a physician refers to a patient of unknown age and gender. Pertinent medical history and drug reactions/allergies were not reported. On 30-JUL-2014, the patient inadvertently received a dose of GARDASIL (dose and route were not reported) instead of (manufacturer unknown) "IPV/polio vaccine". No adverse effect reported. Additional information has been requested.
Sex: U
Vaccine: HPV4, HPV4
Symptoms: Gait disturbance, Injection site pain, Wrong drug administered
Clinical narrative: This spontaneous report as received from a physician refers to a patient of unknown age and gender. Pertinent medical history and drug reactions/allergies were not reported. On 30-JUL-2014, the patient inadvertently received a dose of GARDASIL (dose and route were not reported) instead of (manufacturer unknown) "IPV/polio vaccine". No adverse effect reported. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Redness and swelling right upper arm starting 1 day after receiving DTAP and MMR.
Age: 79.0
Sex: F
Vaccine: PPV
Symptoms: Injection site reaction, Local reaction
Clinical narrative: 07/30 9:45 Pt given extra dose of pneumococcal. From last visit it was noted in chart pt had gotten Zoster and Td and needed PNEUMOVAX at next visit. It wasn't until vaccination given that PNEUMOVAX given already at prior visit and not Zoster. Nurse staff attempted to call patient to be made aware of adverse event. 07/30 10:45 Pt here with localized reaction at injection site. Site erythematous. No reports of fever, shortness of breath or chest pain.
Age: 65.0
Sex: M
Vaccine: PPV, VARZOS
Symptoms: Cold sweat, Decreased appetite, Injection site erythema, Pyrexia
Clinical narrative: Redness at injection site of PNEUMOVAX vaccine left arm, fever, cold sweats, decreased appetite.
Age: 0.33
Sex: F
Vaccine: RV5
Symptoms: Haematochezia
Clinical narrative: Patient had blood in stool after rotavirus vaccine at 2 months that lasted for a few weeks and again at 4 months that just lasted a few days.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Abdominal pain upper, Erythema, Pruritus, Vomiting
Clinical narrative: Patient left clinic and mother came back in saying he complained his stomach hurt and he threw up.  Skin is bright pink and child is scratching. Vital signs 98.1-119-20, BP 96/60, O2 Sat 96%. Seen by MD. Benadryl given and referral to Allergy/Immunology.
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site swelling, Local swelling
Clinical narrative: Patient with progressive severe swelling of entire right arm from mid forearm to anterior chest wall that increased for 48hrs, despite conservative treatment, until administration of IM steroids. This was followed by course of oral steroid taper.
Age: 11.0
Sex: M
Vaccine: HPV4, MEN, TDAP
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Swelling, redness, warmth to left deltoid area
Age: 82.0
Sex: M
Vaccine: PPV
Symptoms: Blood test, Cold sweat, Delirium, Diarrhoea, Endotracheal intubation
Clinical narrative: Fever, delirious, diarrhea, flu-like symptoms, cold sweats; gave Tylenol, checked temperature, contacted a nurse.
Age: 82.0
Sex: M
Vaccine: PPV
Symptoms: Influenza like illness, Intensive care, Pyrexia, X-ray
Clinical narrative: Fever, delirious, diarrhea, flu-like symptoms, cold sweats; gave Tylenol, checked temperature, contacted a nurse.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Seizure like phenomena, Syncope
Clinical narrative: Syncope with seizure like activity lasted ~30 sec.
Age: 33.0
Sex: M
Vaccine: HEP
Symptoms: Chest discomfort, Dyspnoea, Rash
Clinical narrative: Rash, soa, tightness in chest.
Age: 1.41
Sex: M
Vaccine: DTAPHEPBIP, HIBV, MMR, PNC13, VARCEL
Symptoms: Convulsion, Pyrexia
Clinical narrative: Father reported at visit on 7/30/2014 that child had fever of 103 and a seizure three days after vaccines given on 06/30/2014. Child was taken to ER. Father states son did not have any other symptoms prior to the onset of the fever/seizure.
Age: 22.0
Sex: F
Vaccine: HEPA
Symptoms: Dyspnoea, Hyperhidrosis, Rash
Clinical narrative: Sweats, facial rash, difficulty breathing.  Patent took Benadryl and was given Depo Medrol 80mg IM in the office.
Age: 43.0
Sex: F
Vaccine: MMR, MNQ, VARCEL, MMR
Symptoms: Skin warm, Swelling, Tenderness
Clinical narrative: Pt has swelling, slight warm to the touch, 5 cm by 10 cm, painful when touched. Pt received MMR and varicella vaccines 7/30 2014.
Age: 43.0
Sex: F
Vaccine: MMR, MNQ, VARCEL, MMR
Symptoms: Expired drug administered, No adverse event
Clinical narrative: Pt has swelling, slight warm to the touch, 5 cm by 10 cm, painful when touched. Pt received MMR and varicella vaccines 7/30 2014.
Age: 55.0
Sex: F
Vaccine: TDAP
Symptoms: Blood pressure increased, Diarrhoea, Feeling hot, Nausea, Vomiting
Clinical narrative: PATIENT COMPLAINED OF FEELING HOT AND NAUSEATED.  PATIENT VOMITED AND ALSO HAD COMPLAINTS OF DIARRHEA.  PATIENT'S BLOOD PRESSURE SLOWLY INCREASED.
Age: 33.0
Sex: M
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site swelling
Clinical narrative: Redness, swelling, pain, hardness at site, raised swollen painful to touch. Have tried ice pack, Motrin 800mg tid.
Age: 45.0
Sex: F
Vaccine: MMR
Symptoms: Burning sensation, Local swelling, Urticaria
Clinical narrative: Arm burning and swelling. Hives. Returned to office where monitored and Benadryl administered. Ice pack helped swelling subside.  Was given doctor contact info if problems occur later. Physician called later in the evening. Feeling better. Swelling slowly subsiding.
Age: 3.0
Sex: F
Vaccine: DTAPIPVHIB, HEPA
Symptoms: Wrong drug administered
Clinical narrative: Pediarix was given by CMA when Hepatitis A was ordered.   Hep A was also given.
Age: 1.48
Sex: U
Vaccine: HIBV
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and genders. The reporter stated that, on an unspecified date, an unknown number of doses of LIQUID PEDVAXHIB, (dose, lot#, expiration dates not provided) that were stored at 48 degrees F for 20 minutes, then exposed to 47 degrees for 9 minutes have been administered. No adverse effects were reported.   Follow up information had been received on 22-JUL-2014 from a receptionist. The reporter stated that there were two different lot numbers of LIQUID PEDVAXHIB that were included in the temperature excursion: Lot # J016188, expiration date: 02-OCT-2016 and lot # J015437, expiration date: 09-OCT-2016. The receptionist did not have any additional information to share.  Follow-up information has been received from the registered nurse who provided patients details. This report refers to a 19 months old patient of unknown gender. On 06-JUN-2014 the patient was vaccinated with a dose of LIQUID PEDVAXHIB (dose and route were not reported), lot#J016188, expiration date: 02-OCT-2016 that was improperly stored. No adverse effects were reported.  This is one of several reports received from the same reporter. Additional information is not expected.
Age: 0.17
Sex: U
Vaccine: HIBV
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and genders. The reporter stated that, on an unspecified date, an unknown number of doses of LIQUID PEDVAXHIB, (dose, lot#, expiration dates not provided) that were stored at 48 degrees F for 20 minutes, then exposed to 47 degrees for 9 minutes have been administered. No adverse effects were reported.   Follow up information had been received on 22-JUL-2014 from a receptionist. The reporter stated that there were two different lot numbers of LIQUID PEDVAXHIB that were included in the temperature excursion: Lot # J016188, expiration date: 02-OCT-2016 and lot # J015437, expiration date: 09-OCT-2016. The receptionist did not have any additional information to share.  Follow-up information has been received from the registered nurse who provided patients details. This report refers to a 2 months old patient of unknown gender. On 06-JUN-2014 the patient was vaccinated with a dose of LIQUID PEDVAXHIB (dose and route were not reported), lot#J016188, expiration date: 02-OCT-2016 that was improperly stored. No adverse effects were reported.  This is one of several reports received from the same reporter. Additional information is not expected.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site rash, Rash
Clinical narrative: Vaccine administered 7/29/14 - pt reported rash at injection site and on her back at 3:45 pm on 7/31/14 to RPH.
Age: 24.0
Sex: M
Vaccine: TDAP
Symptoms: Headache, Injection site pain, Injection site swelling, Pain
Clinical narrative: Headache, body aches, sore/swollen at site.
Age: 5.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Injection site erythema, Injection site irritation, Injection site pain, Injection site warmth
Clinical narrative: 7/31 vacc given 7/30 at 830 pm irritations right thigh noticed by father 7/31 mother noticed increased redness, warmth, and tenderness. Mother called nurse who had her mark edge of reaction. Worked into clinic injection site red with 3 x 3 uneven circle patient given BENADRYL cream, ZYRTEC for reaction as well as advised to ice.
Age: 55.0
Sex: F
Vaccine: TDAP
Symptoms: Musculoskeletal pain, Periarthritis
Clinical narrative: Patient developed sore shoulder and adhesive capsulitis of (L) shoulder after Tdap injected in (L) deltoid 6/9/14.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Hyperhidrosis, Injection site erythema, Injection site pruritus, Injection site rash
Clinical narrative: Patient called 8/1/14 reported got sweat that evening and little bit of headache -> had raised red area around injection site was itchy at injection site with a small rash around it -> Instructed patient to use ice and apply BENADRYL cream and report if worsens.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site swelling
Clinical narrative: Patient called 8/1/14 reported got sweat that evening and little bit of headache -> had raised red area around injection site was itchy at injection site with a small rash around it -> Instructed patient to use ice and apply BENADRYL cream and report if worsens.
Age: 54.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site irritation, Injection site swelling
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 54 year old male patient with an unspecified pulmonary disorder and drug reaction/allergies to tramadol.  On 21-JUL-2014 the patient was vaccinated with ZOSTAVAX, lot #J014812, expiration date 20-FEB-2015, subcutaneous in the left arm. Dose ws not reported. Concomitant  therapies included oxygen. On 21-JUL-2014, the patient experienced redness, swelling and irritation at the injection site. The area of reaction extended toward the left elbow. The outcome of redness, swelling and irritation at the injection site was reported as recovered (on 28-JUL-2014). No treatment was given for adverse events. No lab diagnostics studies were performed. The patient sought medical attention. Additional information has been requested.
Age: 6.0
Sex: M
Vaccine: DTAPIPV, VARCEL
Symptoms: Pallor, Vomiting
Clinical narrative: Pt stressed concerns about getting shots pale before or after shots given got sick or vomitted after shots given. After getting sick patient laid down was given juice (No dr on between times before seen by provider ) and ice was seem by a provider after 30 minutes only no other symptoms vomitted x 2.
Age: 1.08
Sex: F
Vaccine: HEPA, MMR, VARCEL
Symptoms: Crying, Cyanosis, Dyspnoea, Hypotonia, Loss of consciousness
Clinical narrative: After all 3 immunizations were administered, the child was crying inconsolably, gasping for air. Face and body turned purple and blue. Body went limp for a couple of seconds. Regained consciousness. We administer oxygen and alerted 911. Kept for observation in office.
Age: 27.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: This spontaneous report was received from a Nurse Practitioner refers to a 27 year old female patient. Patient's medical history and drug reactions included Penicillin (anaphylaxis 20 years ago). On an unspecified date in 2009 and 2012 the patient was vaccinated with (Oka/Merck) VARIVAX subcutaneous. No concomitant therapies were reported. On 17-JUL-2014, the patient had blood titer drawn for VZV (Varicella-Zoster virus) antibody level and the results was 0.9gp ELISA units/ml. No treatment was given for the adverse event. The outcome of blood titer drawn for VZV antibody level. The results was 0.9 gp ELISA units/ml was unknown. Additional information has been requested.
Age: 12.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Injection site swelling
Clinical narrative: Swollen left deltoid muscle site of injection, state 1 hr later swelled. ER precautions for cellulitis. RTC PRN. (Ice pack, Ibuprofen).
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Pruritus, Urticaria, Vomiting
Clinical narrative: Vomiting, itching, hives; acute onset 5 minutes after vaccine administration. BENADRYL given PO and EPI 0.15 mg IM. Transported via EMS to Emergency Room.
Age: 26.0
Sex: F
Vaccine: HEP
Symptoms: Nausea, Vision blurred
Clinical narrative: Employee received Hepatitis B vaccine (2nd dose) at approx. 2:15 pm and went to work. The patient reported feeling nausea and blurry vision at approx. 3:45 pm. Temp. prior to vaccine was 99.1 degree F. Temp. at 3:50 pm was 98. 2 degrees F. Pulse = 79, B/P = 161/100. Employee stopped working and rested for about 30 mins. and went back to work. Employee stated she had not eaten prior to coming to work at 2:00 pm. Employee stated had not eaten since 10:30 pm last night. Employee denies illness or being pregnant and prior vaccine.
Age: 53.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Inflammation, Injection site warmth, Pyrexia
Clinical narrative: 7/2 injection 1 day later high fever and inj site "size of softball" and hot to touch. Saw urgent care and prescribed Rx. 7/29 1 month later saw regular MD who dx "shingles" rash on left breast and inflammation on Rt leg.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Patient stated she felt pain, swelling, redness, and warmth in an area 1-2 inches around injection site on 7/29/14. She stated the sign and symptoms decreased significantly after taking BENADRYL. However, her condition is not at pre-vaccination level as of 8/1/14.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unknown number of patients of unknown age and gender. The nurse reported that on an unknown dates, an unknown number of doses of (Oka/Merck) VARIVAX 1350U (dose, route and lot numbers were not reported) that have been exposed to temperature fluctuations of 10 degrees F to 15 degrees F for unspecified times, during defrost cycles, have been administered. No adverse effect reported. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. No pertinent medical history or drug reactions/allergies were provided. The registered nurse reported that doses of ROTATEQ were stored improperly and were administered to an unspecified number of patients (doses and lot numbers not provided), orally on unspecified dates. No adverse effects reported. This case is linked to cases MARRS#1408USA000288 and MARRS#1408USA000499 (same reporter link). Additional information has been requested.
Age: 33.0
Sex: F
Vaccine: HPV4
Symptoms: Papilloma viral infection, Smear cervix abnormal
Clinical narrative: This spontaneous report was received via sales representative from a medical assistant refers to her daughter, a 33 year old female patient. Medical history was not reported. In 2006 (also reported as sometime in 2006) the patient was vaccinated with all the three doses of GARDASIL injection (lot number, expiration date, route and dosage were not reported) for prevention of HPV. Concomitant therapy was not reported. The medical assistant informed that on an unknown date the patient was diagnosed with HPV. A PAP smear was performed. The patient sought medical attention by an office visit and was on an unspecified treatment for the adverse event. The outcome of the event was resolved on unspecified date. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Exposure via direct contact, Eye irrigation, Vision blurred
Clinical narrative: This spontaneous report was received from registered nurse, concerning a female patient of unknown age. On 31-JUL-2014 the patient was vaccinated with a dose of M-M-R II (lot #, dose and route not reported). Concomitant therapy was not reported. On 31-JUL-2014, the patient experienced splashing of M-M-R II into the eyes. On the same day the patient experienced vision blurred. The patient's eyes were flushed with water immediately. The patient sought medical attention, went to occupational health. The outcome of vision blurred was unknown. This is one of two cases from the same source. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Neurological symptom, Personality change
Clinical narrative: This spontaneous report as received from a physician refers to an unspecified patient of unknown age and gender. Medical history and current conditions were not reported. On an unknown date the patient was vaccinated with GARDASIL (intramuscular injection, strength, dose number, route, lot # and expiration date not reported). Concomitant medications were not reported. The reporting physician informed that he overheard a patient experienced a change in personality and had an unknown neurological type reaction after receiving GARDASIL. No further information was provided. Outcome of the events and causality assessment were not provided by the reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with ZOSTAVAX dose 1, 0.65 ml, subcutaneous. On an unknown date, for days after vaccination, the patient experienced 2 inch wide swollen, red area on arm at injection site. The patient did not see any medial attention. The outcome of 2 inch wide swollen, red area on arm at injection site was reported was recovered/resolved.  Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. No pertinent medical history or drug reactions/allergies were reported. The registered nurse reported that doses of GARDASIL were stored improperly and were administered to an unspecified number of patients (doses, routes and lot numbers not provided) on unspecified dates. No adverse effects reported. This case is linked to cases MARRS # 1408USA000499 AND MARRS # 1408USA000500 (same reporter link). Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. No pertinent medical history or drug reactions/allergies were provided. The registered nurse reported that doses of VAQTA were stored improperly and were administered to an unspecified number of patients (doses, routes and lot numbers not provided), on unspecified dates. No adverse effects reported. This case is linked to cases MARRSD # 1408USA000288 and MARRS # 1408USA000500 (same reporter link). Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unspecified number of patients. On an unknown date, the patients were vaccinated with an improperly stored (Oka/Merck) VARIVAX (strength, route, lot number and expiration date not reported) which was exposed to a maximum of -6.8 C for 33  hours. No adverse effects were reported. This is one of two reports received from the same reporter (1407USA012390). Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unspecified number of patients. On an unknown date, the patients were vaccinated with an improperly stored (Oka/Merck) PROQUAD (strength, route, lot number and expiration date not reported) which was exposed to a maximum of -6.8 C for 33 hours. No adverse effects were reported. This is one of two reports received from the same reporter (1407USA013392). Additional information has been requested.
Age: 18.0
Sex: M
Vaccine: MNQ
Symptoms: Angioedema, Blood electrolytes normal, Culture throat negative, Dysphagia, Full blood count normal
Clinical narrative: FEVERS REQUIRING MOTRIN AND TYLENOL GIVEN ALTERNATING EVERY 4 HOURS.  THEN 05/30/2014 0900 THROAT SWELLING UNABLE TO SWALLOW WATER OR PILLS.  FEELING OF SWELLING OF THROAT AND TAKEN TO ER.  ANGIO EDEMA OF THROAT.
Age: 18.0
Sex: M
Vaccine: MNQ
Symptoms: Immediate post-injection reaction, Limb discomfort, Musculoskeletal stiffness, Pharyngeal oedema, Pyrexia
Clinical narrative: FEVERS REQUIRING MOTRIN AND TYLENOL GIVEN ALTERNATING EVERY 4 HOURS.  THEN 05/30/2014 0900 THROAT SWELLING UNABLE TO SWALLOW WATER OR PILLS.  FEELING OF SWELLING OF THROAT AND TAKEN TO ER.  ANGIO EDEMA OF THROAT.
Age: 10.0
Sex: F
Vaccine: DTAP, TDAP
Symptoms: Abdominal pain upper, Crying, Pyrexia, Vomiting
Clinical narrative: Fever over 104, crying, vomiting and severe stomach pain.
Age: 10.0
Sex: F
Vaccine: DTAP, TDAP
Symptoms: Arthralgia, Dizziness, Fatigue, Pain, Pyrexia
Clinical narrative: Fever over 104, crying, vomiting and severe stomach pain.
Age: 10.0
Sex: F
Vaccine: DTAP, TDAP
Symptoms: Vomiting
Clinical narrative: Fever over 104, crying, vomiting and severe stomach pain.
Age: 7.0
Sex: F
Vaccine: HEPA, MMR, TDAP, VARCEL
Symptoms: Urticaria
Clinical narrative: Hives appeared on neck, belly legs all night.
Age: 0.17
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Abnormal behaviour, Crying, Pain, Screaming
Clinical narrative: My child had inconsolable high pitched screaming and crying for 4-5 hours. She NEVER acted like this before. I know she must have been in severe pain as her eyes were begging me to do something to help her and I had no way of doing so. NOTHING i did would help calm her. It was heart wrenching and I almost passed out due to her being so upset.
Age: 0.36
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Injection site rash, Pyrexia
Clinical narrative: Fever of 100.4 started after immunizations approxmately 3 hours. The next day on 8/1/2014 rash on bilateral anterior thighs surrounding the injection site.
Age: 21.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Malaise, Pyrexia, Vaccination site swelling
Clinical narrative: Redness and swelling at the vaccination site, low grade fever, didn't feel well.
Age: 11.0
Sex: F
Vaccine: HPVX, TDAP
Symptoms: Deformity, General physical health deterioration, Quality of life decreased, Rash, Rash generalised
Clinical narrative: Outbreak of white skin patches over entire body, deterioration quickly the entire body disfiguring patient for life, with no answers. Specialist, claims sudden vitiligo, which does not occur in either family history.
Age: 11.0
Sex: F
Vaccine: HPVX, TDAP
Symptoms: Vitiligo
Clinical narrative: Outbreak of white skin patches over entire body, deterioration quickly the entire body disfiguring patient for life, with no answers. Specialist, claims sudden vitiligo, which does not occur in either family history.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site discolouration, Injection site erythema, Pruritus, Rash, Urticaria
Clinical narrative: Hives itch discolored injection site-red than dark, improved with time and Benadryl by 8/2 rash greatly improved, itch almost gone, injection site still discolored.
Age: 21.0
Sex: F
Vaccine: SMALL
Symptoms: Scar
Clinical narrative: Excessive scarring.
Age: 4.0
Sex: M
Vaccine: IPV, MMR, TD
Symptoms: Asthenia, Fatigue, Pruritus, Pyrexia, Swelling
Clinical narrative: Large swollen area resembling hive and itching.  Fever and really tired and weak.
Age: 4.0
Sex: M
Vaccine: IPV, MMR, TD
Symptoms: Urticaria
Clinical narrative: Large swollen area resembling hive and itching.  Fever and really tired and weak.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Swelling  red  itching hot  at injection site
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Burning sensation
Clinical narrative: Patient complained of burning throughout entire arm and shoulder area for 1-2 weeks after administration of SQ shingles vaccination.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Diarrhoea, Headache, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Nausea, diarrhea, headache. Injection site red, sore, swollen - size of egg.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Nausea
Clinical narrative: Nausea, diarrhea, headache. Injection site red, sore, swollen - size of egg.
Age: 0.1
Sex: U
Vaccine: RV5
Symptoms: Drug administered to patient of inappropriate age, No adverse event
Clinical narrative: This spontaneous report as received from a Registered Nurse refers to a 40 week old patient. The patient's medical history and current condition are not reported. It was reported that a 40 weeks old infant was administered dose 3 of ROTATEQ on 29-JUL-2014. No adverse events were reported. Also reported that there is no product quality complaint. The outcome of the events is unknown. Additional information has been requested.
Age: 1.51
Sex: U
Vaccine: HEPA
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a 1 year old patient of unknown gender. The patient's drug allergies and pertinent medical  history was not reported. On 02-JUL-2014 the patient was vaccinated with second dose of VAQTA (dose, frequency and route of administration were not reported) (lot # J005010, expiry date: 23-OCT-2015) which was stored improperly. No adverse effects were noted. No product quality complaint was reported for VAQTA. This case is linked to 1407USA010956, 1407USA012902, 1407USA012903, 1407USA012904, 1407USA012905, 1407USA012906, 1407USA012907, 1407USA012908, 1407USA012909, 1407USA012910, 1407USA012911, 1407USA012912, 1407USA012913, 1407USA012914, 1407USA012915, 1407USA012916, 1407USA012917, 1407USA012918, 1407USA012919, 1407USA012920, 1407USA012921, 1407USA012922, 1407USA012923, 1407USA012924, 1407USA012925, 1407USA012926, 1407USA012927, 1407USA012928, 1407USA012929, 1407USA012930, 1407USA012931, 1407USA012932, 1407USA012933, 1407USA012934, 1407USA012935, 1407USA012936, 1407USA012937, 1407USA012938, 1407USA012939, 1407USA012940, 1407USA012941, 1407USA012942, 1407USA012943, 1407USA012944, 1407USA012945, 1407USA012946, 1407USA012947, 1407USA012948, 1407USA012949. 1407USA012950, 1407USA012951, 1407USA012952, 1407USA012953, 1407USA012954, 1407USA012955, 1407USA012956, 1407USA012957, 1407USA012958, 1407USA012959, 1407USA012960, 1407USA012961. 1407USA012962, 1407USA012963, 1407USA012964, 1407USA012965, 1407USA012966, 1407USA012967, 1407USA012968, 1407USA012969. 1407USA012970, 1407USA012971, 1407USA012972, 1407USA012974, 1407USA012975, 1407USA012976, 1407USA012977. 1407USA012978, 1407USA012979, 1407USA012980, 1407USA012981, 1407USA012982, 1407USA012983, 1407USA012984, 1407USA012985, 1407USA012986, 1407USA012987, 1407USA012988, 1407USA012989, 1407USA012990, 1407USA012991, 1407USA012992, 1407USA012993, 1407USA012994, 1407USA012995, 1407USA012996, 1407USA012997, 1407USA012998, 1407USA012999, 1407USA013000, 1407USA013013 and 1407USA013014 (same reporter link). Additional information has been requested.
Age: 16.0
Sex: U
Vaccine: HEPA
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a 17 year old patient of unknown gender. The patient's drug allergies and pertinent medical history was not reported. On 27-JUN-2014 the patient was vaccinated with second dose of VAQTA (dose, frequency and route of administration were not reported) (lot # J014584, expiry date: 16-JAN-2016) for prophylaxis which was stored improperly. No adverse effects were reported. No product quality complaint was reported for VAQTA. Additional information has been requested.
Sex: F
Vaccine: HIBV
Symptoms: Incorrect storage of drug
Clinical narrative: This spontaneous report as received from a other health professional regarding a female patient of unknown age. On 01-MAY-2014 the patient was vaccinated with LIQUID PEDVAXHIB in the right deltoid. Concomitant medications were not reported. On an unknown date the patient was administered vaccine stored at inappropriate temperature (out of temperature logs). The outcome was unknown. The reporter considered it to be not related to LIQUID PEDVAXHIB. Additional information has been requested.
Age: 1.5
Sex: U
Vaccine: HEPA
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a 1 year old patient of unkonwn gender. The patient's drug allergies and pertinent medical history was not reported. On 15-JUL-2014 the patient was vaccinated with second dose of VAQTA (dose, frequency and route of administration were not reported) (lot # J005010, expiry date; 23-OCT-2015) which was stored improperly. No adverse effects were noted. No product quality complaint was reported for VAQTA. This case is linked to 1407USA010956, 1407USA012902, 1407USA012903, 1407USA012904, , 1407USA012905, 1407USA012906, 1407USA012907, 1407USA012908, 1407USA012909, 1407USA012910, 1407USA012911, 1407USA012912, 1407USA012913, 1407USA012914, 1407USA012915, 1407USA012916, 1407USA012917, 1407USA012918, 1407USA012919, 1407USA012920, 1407USA012921, 1407USA012922, 1407USA012923, 1407USA012924, 1407USA012925, 1407USA012926, 1407USA012927, 1407USA012928, 1407USA012929, 1407USA012930, 1407USA012931, 1407USA012932, 1407USA012933, 1407USA012934, 1407USA012935, 1407USA012936, 1407USA012937, 1407USA012938, 1407USA012939, 1407USA012940, 1407USA012941, 1407USA012942, 1407USA012943, 1407USA012944, 1407USA012945, 1407USA012946, 1407USA012947, 1407USA012948, 1407USA012949, 1407USA012950, 1407USA012951, 1407USA012952, 1407USA012953, 1407USA012954, 1407USA012955, 1407USA012956, 1407USA012957, 1407USA012958, 1407USA012959, 1407USA012960, 1407USA012961, 1407USA012962, 1407USA012963, 1407USA012964, 1407USA012965, 1407USA012966, 1407USA012967, 1407USA012968, 1407USA012969, 1407USA012970, 1407USA012971, 1407USA012972, 1407USA012973, 1407USA012974, 1407USA012976, 1407USA012977, 1407USA012978, 1407USA012979, 1407USA012980, 1407USA012981, 1407USA012982, 1407USA012983, 1407USA012984, 1407USA012985, 1407USA012986, 1407USA012987, 1407USA012988, 1407USA012989, 1407USA012990, 1407USA012991, 1407USA012992, 1407USA012993, 1407USA012994, 1407USA012995, 1407USA012996, 1407USA012997, 1407USA012998, 1407USA012999, 1407USA013000, 1407USA013013 and 1407USA01304 (same reporter link).
Age: 1.01
Sex: U
Vaccine: HEPA
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a 1 year old patient of unknown gender. The patient's drug allergies and pertinent medical history was not reported. On 16-JUN-2014 the patient was vaccinated with first dose of VAQTA (dose, frequency and route of administration were not reported) (lot # J005010, expiry date: 23-OCT-2014) which was stored improperly. No adverse effects were noted. No product quality complaint was reported for VAQTA. Addtional information has been requested.
Age: 17.0
Sex: U
Vaccine: HEPA
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a 17 year old patient of unknown gender. The patient's drug allergies and pertinent medical history was not reported. On 26-JUN-2014 the patient was vaccinated with second dose of VAQTA (dose, frequency and route of administration were not reported) (lot # J011385, expiry date: 10-MAR-2016, also reported as 23-OCT-2015) which was stored improperly. No adverse effects were noted. No product quality complaint was reported for VAQTA. This case is linked to 1407USA010956, 1407USA012902, 1407USA012903, 1407USA012904, , 1407USA012905, 1407USA012906, 1407USA012907, 1407USA012908, 1407USA012909, 1407USA012910, 1407USA012911, 1407USA012912, 1407USA012913, 1407USA012914, 1407USA012915, 1407USA012916, 1407USA012917, 1407USA012918, 1407USA012919, 1407USA012920, 1407USA012921, 1407USA012922, 1407USA012923, 1407USA012924, 1407USA012925, 1407USA012926, 1407USA012927, 1407USA012928, 1407USA012929, 1407USA012930, 1407USA012931, 1407USA012932, 1407USA012933, 1407USA012934, 1407USA012935, 1407USA012936, 1407USA012937, 1407USA012938, 1407USA012939, 1407USA012940, 1407USA012941, 1407USA012942, 1407USA012943, 1407USA012944, 1407USA012945, 1407USA012946, 1407USA012947, 1407USA012948, 1407USA012949, 1407USA012950, 1407USA012951, 1407USA012952, 1407USA012953, 1407USA012954, 1407USA012955, 1407USA012956, 1407USA012957, 1407USA012958, 1407USA012959, 1407USA012960, 1407USA012961, 1407USA012962, 1407USA012963, 1407USA012964, 1407USA012965, 1407USA012966, 1407USA012967, 1407USA012968, 1407USA012969, 1407USA012970, 1407USA012971, 1407USA012972, 1407USA012973, 1407USA012974, 1407USA012975, 1407USA012976, 1407USA012978, 1407USA012979, 1407USA012980, 1407USA012981, 1407USA012982, 1407USA012983, 1407USA012984, 1407USA012985, 1407USA012987, 1407USA012988, 1407USA012989, 1407USA012990, 1407USA012991, 1407USA012992, 1407USA012993, 1407USA012994, 1407USA012995, 1407USA012996, 1407USA012997, 1407USA012998, 1407USA012999, 1407USA013000, 1407USA013013 and 1407USA01304 (same reporter link).
Age: 1.01
Sex: U
Vaccine: HEPA
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a 1 year old patient of unknown gender. The patient's drug allergies and pertinent medical history was not reported. On 24-JUN-2014 the patient was vaccinated with first dose of VAQTA (dose, frequency and route of administration were not reported) (lot # J005010, expiry date: 23-OCT-2015) which was stored improperly. No adverse effects were noted. No product quality complaint was reported for VAQTA. This case is linked to 1407USA010956, 1407USA012902, 1407USA012903, 1407USA012904, , 1407USA012905, 1407USA012906, 1407USA012907, 1407USA012908, 1407USA012909, 1407USA012910, 1407USA012911, 1407USA012912, 1407USA012913, 1407USA012914, 1407USA012915, 1407USA012916, 1407USA012917, 1407USA012918, 1407USA012919, 1407USA012920, 1407USA012921, 1407USA012922, 1407USA012923, 1407USA012924, 1407USA012925, 1407USA012926, 1407USA012927, 1407USA012928, 1407USA012929, 1407USA012930, 1407USA012931, 1407USA012932, 1407USA012933, 1407USA012934, 1407USA012935, 1407USA012936, 1407USA012937, 1407USA012938, 1407USA012939, 1407USA012940, 1407USA012941, 1407USA012942, 1407USA012943, 1407USA012944, 1407USA012945, 1407USA012946, 1407USA012947, 1407USA012948, 1407USA012949, 1407USA012950, 1407USA012951, 1407USA012952, 1407USA012953, 1407USA012954, 1407USA012955, 1407USA012956, 1407USA012957, 1407USA012958, 1407USA012959, 1407USA012960, 1407USA012961, 1407USA012962, 1407USA012963, 1407USA012964, 1407USA012965, 1407USA012966, 1407USA012967, 1407USA012968, 1407USA012969, 1407USA012970, 1407USA012971, 1407USA012972, 1407USA012973, 1407USA012974, 1407USA012975, 1407USA012976, 1407USA012977, 1407USA012979, 1407USA012980, 1407USA012981, 1407USA012982, 1407USA012983, 1407USA012984, 1407USA012985, 1407USA012986, 1407USA012987, 1407USA012988, 1407USA012989, 1407USA012990, 1407USA012991, 1407USA012992, 1407USA012993, 1407USA012994, 1407USA012995, 1407USA012996, 1407USA012997, 1407USA012998, 1407USA012999, 1407USA013000, 1407USA013013 and 1407USA01304 (same reporter link).
Age: 1.01
Sex: U
Vaccine: HEPA
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a 1 year old patient of unknown gender. The patient's drug allergies and pertinent medical history was not reported. On 08-JUL-2014 the patient was vaccinated with first dose of VAQTA (dose, frequency and route of administration were not reported) (lot # J005010, expiry date: 23-OCT-2014) which was stored improperly. No adverse effects were noted. No product quality complaint was reported for VAQTA. Addtional information has been requested.
Age: 1.01
Sex: U
Vaccine: HEPA
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a 1 year old patient of unknown gender. The patient's drug allergies and pertinent medical history was not reported. On 08-JUL-2014 the patient was vaccinated with first dose of VAQTA, (dose, frequency and route of administration were not reported) (lot # J005010, expiry date: 23-OCT-2015) which was stored improperly. No adverse effects were noted. No product quality complaint was reported for VAQTA. This case is linked to 1407USA010956, 1407USA012902, 1407USA012903, 1407USA012904, , 1407USA012905, 1407USA012906, 1407USA012907, 1407USA012908, 1407USA012909, 1407USA012910, 1407USA012911, 1407USA012912, 1407USA012913, 1407USA012914, 1407USA012915, 1407USA012916, 1407USA012917, 1407USA012918, 1407USA012919, 1407USA012920, 1407USA012921, 1407USA012922, 1407USA012923, 1407USA012924, 1407USA012925, 1407USA012926, 1407USA012927, 1407USA012928, 1407USA012929, 1407USA012930, 1407USA012931, 1407USA012932, 1407USA012933, 1407USA012934, 1407USA012935, 1407USA012936, 1407USA012937, 1407USA012938, 1407USA012939, 1407USA012940, 1407USA012941, 1407USA012942, 1407USA012943, 1407USA012944, 1407USA012945, 1407USA012946, 1407USA012947, 1407USA012948, 1407USA012949, 1407USA012950, 1407USA012951, 1407USA012952, 1407USA012953, 1407USA012954, 1407USA012955, 1407USA012956, 1407USA012957, 1407USA012958, 1407USA012959, 1407USA012960, 1407USA012961, 1407USA012962, 1407USA012963, 1407USA012964, 1407USA012965, 1407USA012966, 1407USA012967, 1407USA012968, 1407USA012969, 1407USA012970, 1407USA012971, 1407USA012972, 1407USA012973, 1407USA012974, 1407USA012975, 1407USA012976, 1407USA012977, 1407USA012978, 1407USA012979, 1407USA012981, 1407USA012982, 1407USA012983, 1407USA012984, 1407USA012985, 1407USA012987, 1407USA012988, 1407USA012989, 1407USA012990, 1407USA012991, 1407USA012992, 1407USA012993, 1407USA012994, 1407USA012995, 1407USA012996, 1407USA012997, 1407USA012998, 1407USA012999, 1407USA013000, 1407USA013013 and 1407USA01304 (same reporter link).